Cat. No. 1295
Chemical Name: (Z)-1-[2-Chloro-2-(2,4-dichlorophen
Biological ActivitySubtype-selective GABAA receptor modulator. Acts as a positive allosteric modulator of β2 or β3-subunit containing receptors. Also acts as a negative modulator at a novel regulatory site, enhancing GABAA receptor sensitization. Inhibits homomeric ρ1 GABAC receptors.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Smith et al (2004) Compounds exhibiting selective efficacy for different β subunits of human recombinant γ-aminobutyric acidA receptors. J.Pharmacol.Exp.Ther. 311 601. PMID: 15210837.
Fisher et al (2000) Loreclezole inhibition of recombinant α1β1γ2L GABAA receptor single channel currents. Neuropharmacology 39 235. PMID: 10670419.
Thomet et al (2000) Loreclezole as a simple functional marker for homomeric ρ type GABAC receptors. Eur.J.Pharmacol. 408 R1. PMID: 11080529.
Donnelly and Macdonald (1996) Loreclezole enhances apparent desensitisation of recombinant GABAA receptor currents. Neuropharmacology 35 1233. PMID: 9014138.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Loreclezole hydrochloride include:
Kotak et al (2008) Hearing loss prevents the maturation of GABAergic transmission in the auditory cortex. Mol Med 18 2098. PMID: 18222937.
Do you know of a great paper that uses Loreclezole hydrochloride from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Loreclezole hydrochloride, supplier, Subtype-selective, GABAA, receptor, modulators, Receptors, positive, allosteric, PAM, Tocris Bioscience, GABAA Receptor Modulator products
Find multiple products by catalog number
April 22 - 26, 2017
Chicago, IL, USA